Jon E. Angell

Array ( [id] => 435750 [patent_doc_number] => 07262005 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-28 [patent_title] => 'Methods of protein destabilization and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/498098 [patent_app_country] => US [patent_app_date] => 2000-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 32063 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262005.pdf [firstpage_image] =>[orig_patent_app_number] => 09498098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 442434 [patent_doc_number] => 07255987 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-14 [patent_title] => 'Selecting animals for parentally imprinted traits' [patent_app_type] => utility [patent_app_number] => 09/868732 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 12 [patent_no_of_words] => 16411 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/255/07255987.pdf [firstpage_image] =>[orig_patent_app_number] => 09868732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1018017 [patent_doc_number] => 06890911 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Method for the treatment of inflammation' [patent_app_type] => utility [patent_app_number] => 09/857333 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2969 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890911.pdf [firstpage_image] =>[orig_patent_app_number] => 09857333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618951 [patent_doc_number] => 07998667 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-08-16 [patent_title] => 'Mutations of the parkin gene, compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 09/856290 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 14585 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998667.pdf [firstpage_image] =>[orig_patent_app_number] => 09856290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 246871 [patent_doc_number] => 07585622 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-09-08 [patent_title] => 'Increasing the proliferative capacity of cells using telomerase reverse transcriptase' [patent_app_type] => utility [patent_app_number] => 09/432503 [patent_app_country] => US [patent_app_date] => 1999-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 123 [patent_no_of_words] => 102712 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585622.pdf [firstpage_image] =>[orig_patent_app_number] => 09432503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1373364 [patent_doc_number] => 06562800 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Use of immunopotentiating sequences for inducing immune response' [patent_app_type] => B1 [patent_app_number] => 09/430470 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 15001 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562800.pdf [firstpage_image] =>[orig_patent_app_number] => 09430470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402889 [patent_doc_number] => 20020037274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'SINGLE AGENT METHOD FOR KILLING TUMOR AND TUMOR ASSOCIATED ENDOTHELIAL CELLS USING ADENOVIRAL MUTANTS' [patent_app_type] => new [patent_app_number] => 09/410462 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8144 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037274.pdf [firstpage_image] =>[orig_patent_app_number] => 09410462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598213 [patent_doc_number] => 20020042383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'METHYLATION AND/Or CpG REMOVAL OF PLASMID VECTORS' [patent_app_type] => new [patent_app_number] => 09/392462 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15120 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042383.pdf [firstpage_image] =>[orig_patent_app_number] => 09392462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982045 [patent_doc_number] => 06926888 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-09 [patent_title] => 'Alginate capsules for use in the treatment of brain tumor' [patent_app_type] => utility [patent_app_number] => 09/763682 [patent_app_country] => US [patent_app_date] => 1999-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9240 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/926/06926888.pdf [firstpage_image] =>[orig_patent_app_number] => 09763682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1153571 [patent_doc_number] => 06764676 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-20 [patent_title] => 'Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus' [patent_app_type] => B1 [patent_app_number] => 09/378810 [patent_app_country] => US [patent_app_date] => 1999-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20673 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/764/06764676.pdf [firstpage_image] =>[orig_patent_app_number] => 09378810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 768910 [patent_doc_number] => 07005299 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-28 [patent_title] => 'Expression of heterologous genes according to a targeted expression profile' [patent_app_type] => utility [patent_app_number] => 09/348469 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 8801 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/005/07005299.pdf [firstpage_image] =>[orig_patent_app_number] => 09348469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073780 [patent_doc_number] => 06838445 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-04 [patent_title] => 'Tumor antigen peptide originating in SART-1' [patent_app_type] => utility [patent_app_number] => 09/743467 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9937 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838445.pdf [firstpage_image] =>[orig_patent_app_number] => 09743467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6208271 [patent_doc_number] => 20020071824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'GENE TRANSFER TO PANCREATIC B CELLS FOR PREVENTION OF ISLET DYSFUNCTION' [patent_app_type] => new [patent_app_number] => 09/320767 [patent_app_country] => US [patent_app_date] => 1999-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13961 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20020071824.pdf [firstpage_image] =>[orig_patent_app_number] => 09320767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059613 [patent_doc_number] => 06852703 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-08 [patent_title] => 'Tumor targeted vector' [patent_app_type] => utility [patent_app_number] => 09/445375 [patent_app_country] => US [patent_app_date] => 1998-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 21442 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852703.pdf [firstpage_image] =>[orig_patent_app_number] => 09445375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6840004 [patent_doc_number] => 20030037344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'METHOD FOR EVALUATING THE ABILITY OF A COMPOUND TO INHIBIT NEUROTOXICITY' [patent_app_type] => new [patent_app_number] => 08/997464 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6491 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20030037344.pdf [firstpage_image] =>[orig_patent_app_number] => 08997464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999298 [patent_doc_number] => 20020028212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'RECOMBINANT VIRUSES CODING FOR A GLUTAMATE DECARBOXYLASE (GAD) ACTIVITY' [patent_app_type] => new [patent_app_number] => 08/704583 [patent_app_country] => US [patent_app_date] => 1996-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9336 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028212.pdf [firstpage_image] =>[orig_patent_app_number] => 08704583 [rel_patent_id] =>[rel_patent_doc_number] =>)